RISPOVAL RS
RISPOVAL RS
Authorised
- Bovine respiratory syncytial virus, strain RB94, Live
Product identification
Medicine name:
RISPOVAL RS
Active substance:
- Bovine respiratory syncytial virus, strain RB94, Live
Target species:
-
Cattle
-
Cattle (for meat production)
-
Cattle (calf)
-
Cattle (heifer)
-
Cattle (suckling calf)
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Bovine respiratory syncytial virus, strain RB94, Live31622800.00tissue culture infective dose 501.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Cattle
-
Meat and offal0day
-
Milk0day
-
- Cattle (for meat production)
-
Meat and offal0day
-
- Cattle (calf)
-
Meat and offal0day
-
- Cattle (heifer)
-
Meat and offal0day
-
- Cattle (suckling calf)
-
Milk0day
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI02AD04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Paul-Ehrlich-Institut
Authorisation number:
- 116a/89
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 27/02/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 27/02/2024
How useful was this page?: